Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
BEAMCompany Name
BEAM THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBEAM THERAPEUTICS INC - Price to Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BEAM - P/FCF Historical data
| Date | Free Cash Flow | Market Capitalization | Price to Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ -355.57M | $ 1.89B | 0 |
| 3/31/2025 | $ -360.96M | $ 1.61B | 0 |
| 12/31/2024 | $ -356.19M | $ 2.5B | 0 |
| 9/30/2024 | $ -145.37M | $ 1.98B | 0 |
| 6/30/2024 | $ -153.4M | $ 2.1B | 0 |
| 3/31/2024 | $ -169.28M | $ 1.85B | 0 |
| 12/31/2023 | $ -182.93M | $ 3.68B | 0 |
| 9/30/2023 | $ -391.86M | $ 1.87B | 0 |
| 6/30/2023 | $ -380.41M | $ 2.08B | 0 |
| 3/31/2023 | $ -353.49M | $ 2.73B | 0 |
Key Performance Insights, Last 5 Years
- BEAM THERAPEUTICS INC's latest trailing twelve months (TTM) P/FCF stands at 0.
- Over the past 5 years, BEAM THERAPEUTICS INC's average P/FCF has been 39.43.
- The median P/FCF for BEAM THERAPEUTICS INC during this period was 34.87
- BEAM THERAPEUTICS INC reached its highest P/FCF over the past 5 years at 67.65.
- The lowest P/FCF recorded by BEAM THERAPEUTICS INC in the same timeframe 15.78
Similar metrics to P/FCF:
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
Definition of Price to Free Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].Market Cap / FCF
(=) P/FCF P/FCF for BEAM THERAPEUTICS INC is calculated as follows: Market Cap [ $ 2.18B ] / FCF [ $ -99.64M ]
(=) P/FCF [ 0 ] BEAM - Price to Free Cash Flow, Last 5 years
15.78
Minimum
Mar 31, 2022
67.65
Maximum
Sep 30, 2022
39.43
Average
34.87
Median
P/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.33 with a standard deviation of 12.94.
The following table provides additional summary stats:
P/FCF in the Market:
| filtered constituents | 2.23K |
|---|---|
| min | 0.06 |
| max | 60.45 |
| average | 18.33 |
| median | 14.76 |
| std | 12.94 |